Coordinating cancer clinical trials across the Parkville Precinct
PARKVILLE CANCER CLINICAL TRIALS UNIT
The Parkville Cancer Clinical Trials Unit (PCCTU) is Australia’s largest cancer clinical trials unit, specialising in first in human, phase I, medical oncology, haematology, and palliative care clinical trials.
In August 2016, the Parkville Cancer Clinical Trials Unit (PCCTU) amalgamated the cancer clinical trials units of Peter MacCallum Cancer Centre, The Royal Melbourne Hospital and The Royal Women’s Hospital. The PCCTU is located in the purpose built Victorian Comprehensive Cancer Centre building in Parkville, Melbourne.
PCCTU Profile
Internationally recognised Investigators with expertise and experience in:
- The conduct of cancer clinical trials
- Basic research, translational research and biomarker development
- Collaborations with national and international Investigators
- Novel clinical trial design
Ten multi-disciplinary research teams based on tumour stream.
A dedicated clinical trial treatment area and facilities.
Strategically located, PCCTU delivers a precinct service with premier results. This provides access to a comprehensive range of specialised medical services, for example:
- Shared pathology service
- Clinical trials pharmacy
- Imaging
- Ophthalmology
- Intensive Care Unit
- Shared medical record
- Specialty clinics
- Translational expertise and leading edge laboratory service
To approach PCCTU with a potential clinical trial, email through:
- Mutual Confidentiality Agreement in editable word format (if required)
- Protocol or synopsis
- Timelines
- Number of sites
- Number of participants
To the Feasibility Coordinator and Tumour Stream lead per below stream profiles.
Feasibility Coordinator
Business hours, Monday to Friday
Email PCCTU.Feasibility@Petermac.org
Phone +61 3 8559 7350 or +61 3 8559 7958
PCCTU site profile is available through the Shared Investigator Platform.
The Early Drug Development (EDD) / Phase One team specialises in complex and first in human clinical trials, run by dedicated investigators and research staff with early drug development experience and expertise.
Early Drug Development Lead
A/Prof Jayesh Desai
Jayesh.Desai@petermac.org
Clinical Haematology is a unified department formed between Peter Mac and the Royal Melbourne Hospital and is the largest haematology service in the country, offering a broad clinical trials program.
The Clinical Haematology program offers a wide range of advanced research treatments for many of the Peter Mac and Royal Melbourne patients.
Clinical Haematology is a unified department formed between Peter Mac and the Royal Melbourne Hospital and is the largest haematology service in the country, offering a broad clinical trials program.
The Clinical Haematology program offers a wide range of advanced research treatments for many of the Peter Mac and Royal Melbourne patients.
Haematology Leads
Acute Leukaemias and Myelodysplastic Syndromes
Dr Ashish Bajel
Ashish.Bajel@mh.org.au
Hodgkin Lymphoma and Aggressive non-Hodgkin Lymphoma
Dr Michael Dickinson
Michael.Dickinson@petermac.org
Allogeneic Bone Marrow Transplant
Prof David Ritchie
David.Ritchie@petermac.org
Chronic Myeloid Leukaemia and Myeloproliferative Neoplasms
A/Prof Kate Burbury
Kate.Burbury@petermac.org
Indolent non-Hodgkin Lymphoma and T-cell Lymphoproliferative Disease
Prof Constantine Tam
Constantine.Tam@petermac.org
Late Effects and Survivorship
A/Prof Kylie Mason
Kylie.Mason@petermac.org
Multiple Myeloma
A/Prof Simon Harrison
Simon.Harrison@petermac.org
Non-malignant Haematology
A/Prof Kylie Mason
Kylie.Mason@petermac.org
The Medical Oncology tumour streams delivers world-class cancer care, backed by an uncompromising commitment to research, clinical trials and evidence-based practice to ensure the best possible outcome for patients.
Medical Oncology Leads
Breast Cancer
Prof Sherene Loi
Sherene.Loi@petermac.org
Gynaecological Cancers
A/Prof Linda Mileshkin
Linda.Mileshkin@petermac.org
Upper Gastro-Intestinal Cancers
A/Prof Michael Michael
Michael.Michael@petermac.org
Lower Gastro-Intestinal Cancers
A/Prof Jeanne Tie
Jeanne.Tie@petermac.org
Head and Neck and Cutaneous Squamous Cell Carcinoma
Prof Danny Rischin
Danny.Rischin@petermac.org
Lung Cancer
Prof Ben Solomon
Ben.Solomon@petermac.org
Neurological Cancer
Prof Mark Rosenthal
Mark.Rosenthal@petermac.org
Sarcoma
A/Prof Jayesh Desai
Jayesh.Desai@petermac.org
Urological Cancer
Dr Ben Tran
Ben.Tran@petermac.org
Melanoma and Skin Cancer
A/Prof Shahneen Sandhu
Shahneen.Sandhu@petermac.org
Palliative Care
A/Prof Brian Le
Brian.Le@petermac.org
Director
Professor Mark Rosenthal
Mark.Rosenthal@petermac.org
Deputy-Director
Associate Professor Jayesh Desai
Jayesh.Desai@Petermac.Org
Manager
Ms Marian Lieschke
Marian.Lieschke@petermac.org
Phone +61 3 8559 7140
Deputy Manager
Ms Kylie Shackleton
Kylie.Shackleton@petermac.org
Phone +61 3 8559 6205
Feasibility Coordinators
Ms Maryanne Turner
PCCTU.Feasibility@petermac.org
Phone +61 3 8559 7350
Ms Safia Humam
PCCTU.Feasibility@petermac.org
Phone +61 3 8559 7958